HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

She-Gan Gao Selected Research

Syndecan-3

6/2017Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreatic cancer.
3/2014Midkine promotes perineural invasion in human pancreatic cancer.
10/2013Pleiotrophin promotes perineural invasion in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


She-Gan Gao Research Topics

Disease

17Neoplasms (Cancer)
08/2021 - 01/2003
7Adenocarcinoma
09/2017 - 01/2003
6Esophageal Squamous Cell Carcinoma
01/2022 - 01/2003
6Neoplasm Metastasis (Metastasis)
01/2020 - 01/2012
6Pancreatic Neoplasms (Pancreatic Cancer)
06/2017 - 10/2013
3Esophageal Neoplasms (Esophageal Cancer)
06/2017 - 01/2003
3Carcinoma (Carcinomatosis)
05/2013 - 01/2003
2Liver Neoplasms (Liver Cancer)
01/2018 - 06/2015
2Carcinogenesis
01/2018 - 01/2012
2Stomach Neoplasms (Stomach Cancer)
01/2016 - 01/2013
2Gastritis
06/2015 - 01/2012
2Metaplasia
06/2013 - 01/2012
2Hyperplasia
05/2013 - 01/2003
1COVID-19
02/2022
1Mental Disorders (Mental Disorder)
01/2020
1Diabetes Complications
01/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2018
1Esophagitis
01/2018
1Inflammation (Inflammations)
01/2018
1Lung Neoplasms (Lung Cancer)
01/2018
1Ameloblastoma
01/2015
1Neuritis (Polyneuritis)
01/2015
1Necrosis
10/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2013
1Infections
05/2013
1Papillomavirus Infections
05/2013
1Carcinoma in Situ
01/2003

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2003
6Biomarkers (Surrogate Marker)IBA
08/2021 - 04/2015
3Pharmaceutical PreparationsIBA
02/2022 - 06/2017
3Syndecan-3IBA
06/2017 - 10/2013
3MidkineIBA
01/2015 - 03/2014
2Messenger RNA (mRNA)IBA
01/2022 - 08/2021
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 11/2014
2Long Noncoding RNAIBA
01/2020 - 01/2018
2Docetaxel (Taxotere)FDA Link
10/2018 - 06/2017
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 01/2015
2pleiotrophin (HARP)IBA
06/2017 - 10/2013
1AZD8186IBA
10/2018
1Macrophage Migration-Inhibitory FactorsIBA
01/2018
1MicellesIBA
01/2018
1Cell-Free Nucleic AcidsIBA
01/2018
1osimertinibIBA
01/2018
1AntibodiesIBA
01/2018
1Paclitaxel (Taxol)FDA LinkGeneric
01/2018
1CytokinesIBA
01/2018
1DisulfidesIBA
01/2018
1EnzymesIBA
01/2018
1Immunoglobulin A (IgA)IBA
01/2018
1Immunoglobulin G (IgG)IBA
01/2018
1ImmunosorbentsIBA
01/2018
1Bortezomib (Velcade)FDA Link
06/2017
1LigandsIBA
01/2016
1ArgonIBA
06/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2015
1Transcription Factor CHOPIBA
06/2015
1HeliumIBA
06/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2015
1Carcinoembryonic AntigenIBA
04/2015
1CarbohydratesIBA
04/2015
1AntigensIBA
04/2015
1Biological ProductsIBA
01/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2015
1Nerve Growth Factors (Neurotrophins)IBA
01/2015
1Estrogen ReceptorsIBA
11/2014
1AvidinIBA
06/2013
1Periodic AcidIBA
06/2013
1Peroxidase (Myeloperoxidase)IBA
06/2013
1Biotin (Vitamin H)FDA Link
06/2013
1Alcian BlueIBA
06/2013
1high iron diamine-alcian blueIBA
06/2013
1telomerase RNA (bTR)IBA
05/2013
1DNA (Deoxyribonucleic Acid)IBA
05/2013
1Fluorouracil (Carac)FDA LinkGeneric
01/2013
1NF-E2-Related Factor 2IBA
01/2013
1CDX2 Transcription FactorIBA
01/2012
1villinIBA
01/2012
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2011
1Therapeutic UsesIBA
12/2011
1Dihematoporphyrin Ether (Porfimer Sodium)FDA Link
12/2009
11-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2009
1Photosensitizing Agents (Photosensitizers)IBA
12/2009
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2003

Therapy/Procedure

6Therapeutics
02/2022 - 01/2015
2Cryosurgery
06/2015 - 04/2015
1Aftercare (After-Treatment)
04/2015
1Radiotherapy
01/2015
1Drug Therapy (Chemotherapy)
01/2015
1Pancreaticoduodenectomy
03/2014
1Combination Drug Therapy (Combination Chemotherapy)
12/2011
1Photochemotherapy (Photodynamic Therapy)
12/2009